According to Bloomberg.com, “Shire Plc is in advanced talks to acquire Baxalta Inc. for about $32 billion in cash and stock, excluding debt, according to people familiar with the matter. The two drugmakers may announce a deal as soon as this week, the people said, asking not to be identified as the matter isn’t public.” For more information on this deal, please visit: http://www.bloomberg.com/news/articles/2016-01-03/shire-said-in-advanced-talks-to-acquire-u-s-drugmaker-baxalta